NOV Inc. NOV
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Stephen Gengaro |
Stifel Nicolaus |
12.01 $ |
23 $ |
10.99 % |
15/04/2025 |
| Keith Mackey |
RBC Capital |
15.12 $ |
22 $ |
6.88 % |
24/03/2025 |
| David Anderson |
Barclays |
14.19 $ |
12 $ |
-2.19 % |
18/12/2024 |
| Stephen Gengaro |
Stifel Nicolaus |
16.25 $ |
25 $ |
8.75 % |
11/10/2024 |
| Phillip Jungwirth |
BMO Capital |
15.93 $ |
20 $ |
4.07 % |
10/10/2024 |
| Daniel Kutz |
Morgan Stanley |
15.86 $ |
23 $ |
7.14 % |
16/09/2024 |
| David Anderson |
Barclays |
19.81 $ |
20 $ |
0.19 % |
30/07/2024 |
| James West |
Evercore ISI |
16.17 $ |
22 $ |
5.83 % |
04/02/2022 |
| Marc Bianchi |
Cowen & Co. |
13.49 $ |
19 $ |
5.51 % |
09/12/2021 |
| Connor Lynagh |
Morgan Stanley |
14.43 $ |
17 $ |
2.57 % |
11/10/2021 |
| Phillip Jungwirth |
BMO Capital |
13.15 $ |
15 $ |
1.85 % |
19/07/2021 |
| Vaibhav Vaishnav |
Coker Palmer |
15.46 $ |
12 $ |
-3.46 % |
04/05/2021 |